The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The Survival Benefits of AIDS Treatment in the United States
Abstract
BACKGROUND: As widespread adoption of potent combination antiretroviral therapy (ART) reaches its tenth year, our objective was to quantify the cumulative survival benefits of acquired immunodeficiency syndrome (AIDS) care in the United States. METHODS: We defined eras corresponding to advances in standards of human immunodeficiency virus (HIV) disease care, including opportunistic infection prophylaxis, treatment with ART, and the prevention of mother-to-child transmission (pMTCT) of HIV. Per-person survival benefits for each era were determined using a mathematical simulation model. Published estimates provided the number of adult patients with new diagnoses of AIDS who were receiving care in the United States from 1989 to 2003. RESULTS: Compared with survival associated with untreated HIV disease, per-person survival increased 0.26 years with Pneumocystis jiroveci pneumonia prophylaxis alone. Four eras of increasingly effective ART in addition to prophylaxis resulted in per-person survival increases of 7.81, 11.05, 11.57, and 13.33 years, compared with the absence of treatment. Treatment for patients with AIDS in care in the United States since 1989 yielded a total survival benefit of 2.8 million years. pMTCT averted nearly 2900 infant infections, equivalent to 137,000 additional years of survival benefit. CONCLUSIONS: At least 3.0 million years of life have been saved in the United States as a direct result of care of patients with AIDS, highlighting the significant advances made in HIV disease treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M. J., VanDyke, R., Bey, M., Shearer, W., Jacobson, R. L., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311801 · Cited by 3,705
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332305 · Cited by 2,439
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341
Cooper, E. R., Charurat, M., Mofenson, L., Hanson, I. C., Pitt, J., Diaz, C., Hayani, K., Handelsman, E., Smeriglio, V., Hoff, R., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204150-00009 · Cited by 1,058
Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412501 · Cited by 993
Rosamond, W. D., Chambless, L. E., Folsom, A. R., Cooper, L. S., Conwill, D. E., Clegg, L., Wang, C.-H., & Heiss, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391301 · Cited by 827
Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Senterfitt, J. W., Fleishman, J. A., Perlman, J. F., Athey, L. A., Keesey, J. W., Goldman, D. P., Berry, S. H., et al. (1999) · JAMA · doi:10.1001/jama.281.24.2305 · Cited by 704
Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 625
Masur, P. B. H., Kaplan, J. E., & Holmes, K. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00002 · Cited by 567
Expanded Screening for HIV in the United States — An Analysis of Cost-Effectiveness
Paltiel, A. D., Weinstein, M. C., Kimmel, A. D., Seage, G. R., Losina, E., Zhang, H., Freedberg, K. A., & Walensky, R. P. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042088 · Cited by 553
Self-citationThe Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Freedberg, K. A., Losina, E., Weinstein, M. C., Paltiel, A. D., Cohen, C. J., Seage, G. R., Craven, D. E., Zhang, H., Kimmel, A. D., & Goldie, S. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441108 · Cited by 508
Self-citationBaxter, J. D., Mayers, D. L., Wentworth, D. N., Neaton, J. D., Hoover, M. L., Winters, M. A., Mannheimer, S., Thompson, M., Abrams, D. I., Brizz, B., et al. (2000) · AIDS · doi:10.1097/00002030-200006160-00001 · Cited by 494
Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS
Nightingale, S. D., Cameron, D. W., Gordin, F. M., Sullam, P. M., Cohn, D. L., Chaisson, R. E., Eron, L. J., Sparti, P. D., Bihari, B., Kaufman, D. L., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309163291202 · Cited by 394
Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes
Wright, J. C., & Weinstein, M. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390606 · Cited by 334
Self-citationHavlir, D. V., Dubé, M. P., Sattler, F. R., Forthal, D. N., Kemper, C. A., Dunne, M. W., Parenti, D. M., Lavelle, J. P., White, A. C., Witt, M. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350604 · Cited by 329
Ivers, L. C., Kendrick, D., & Doucette, K. (2005) · Clinical Infectious Diseases · doi:10.1086/431199 · Cited by 312
Cole, S. R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg206 · Cited by 270
Johnson, M., Grinsztejn, B., Rodriguez, C., Coco, J., DeJesus, E., Lazzarin, A., Lichtenstein, K., Rightmire, A., Sankoh, S., & Wilber, R. (2005) · AIDS · doi:10.1097/01.aids.0000166091.39317.99 · Cited by 248
The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections
Freedberg, K. A. (1998) · JAMA · doi:10.1001/jama.279.2.130 · Cited by 243
Self-citationUse of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness
Weinstein, M. C., Goldie, S. J., Losina, E., Cohen, C. J., Baxter, J. D., Zhang, H., Kimmel, A. D., & Freedberg, K. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-6-200103200-00008 · Cited by 235
Self-citationA Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens
Ioannidis, J. P. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440020081010 · Cited by 197
United States life tables, 2002.
Arias, E. (2004) · PubMed · Cited by 188
Schneider, M. F., Gange, S. J., Williams, C. M., Anastos, K., Greenblatt, R. M., Kingsley, L., Detels, R., & Muñoz, Á. (2005) · AIDS · doi:10.1097/01.aids.0000189864.90053.22 · Cited by 137
Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV
Massad, L. S., Springer, G., Jacobson, L. P., Watts, H. D., Anastos, K., Korn, A. P., Cejtin, H. E., Stek, A. M., Young, M., Schmidt, J., et al. (2004) · AIDS · doi:10.1097/00002030-200401230-00018 · Cited by 137
Cost-effectiveness of Routine Coronary Angiography After Acute Myocardial Infarction
Kuntz, K. M., Tsevat, J., Goldman, L., & Weinstein, M. C. (1996) · Circulation · doi:10.1161/01.cir.94.5.957 · Cited by 125
Self-citationNelfinavir, Efavirenz, or Both after the Failure of Nucleoside Treatment of HIV Infection
Albrecht, M., Bosch, R. J., Hammer, S. M., Liou, S.-H., Kessler, H. A., Para, M. F., Eron, J. J., Valdez, H., Dehlinger, M., & Katzenstein, D. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450602 · Cited by 122
Health and Economic Benefits of Increased β-Blocker Use Following Myocardial Infarction
Phillips, K. A. (2000) · JAMA · doi:10.1001/jama.284.21.2748 · Cited by 112
Long-term Exposure to Lifelong Therapies
Powderly, W. G. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200202011-00005 · Cited by 111
Weintraub, W. S., Mahoney, E. M., Lamy, A. L., Culler, S. D., Yuan, Y., Caro, J. J., Gabriel, S., & Yusuf, S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.051 · Cited by 106
Access to therapy in the multicenter AIDS Cohort Study, 1989–1992
Graham, N. M. H., Jacobson, L. P., Kuo, V., Chmiel, J. S., Morgenstern, H., & Zucconi, S. L. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90115-5 · Cited by 102
Moore, R. D., Keruly, J. C., Gebo, K. A., & Lucas, G. M. (2005) · PubMed · Cited by 88
Trends in Pregnancy Rates Among Women With Human Immunodeficiency Virus
Blair, J. M., Hanson, D. L., Jones, J. L., et al. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000117083.33239.b5 · Cited by 84
Peters, V. B., Liu, K.-L., Gill, B., et al. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0822 · Cited by 82
Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer
Berthelot, J., Will, B. P., Evans, W. K., Coyle, D., Earle, C. C., & Bordeleau, L. J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1321 · Cited by 72
Clotet, B., Raffi, F., Cooper, D. A., Delfraissy, J., Lazzarin, A., Moyle, G. J., Rockstroh, J. K., Soriano, V., & Schapiro, J. (2004) · AIDS · doi:10.1097/00002030-200405210-00007 · Cited by 71
Cost-effectiveness Implications of the Timing of Antiretroviral Therapy in HIV-Infected Adults
Schackman, B. R., Freedberg, K. A., Weinstein, M. C., Sax, P. E., Losina, E., Zhang, H., & Goldie, S. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2478 · Cited by 68
Self-citationCost-Effectiveness of HIV Screening for Incarcerated Pregnant Women
Resch, S., Altice, F. L., & Paltiel, A. D. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000146598.40301.e6 · Cited by 29
Self-citationPrimary Prophylaxis against Opportunistic Infections in Patients with AIDS
Clumeck, N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321109 · Cited by 22
Cited by
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
De Clercq, E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.010 · Cited by 627
Retention in Care: A Challenge to Survival with HIV Infection
Giordano, T. P., Gifford, A. L., White, A. C., Almazor, M. E. S., Rabeneck, L., Hartman, C., Backus, L. I., Mole, L. A., & Morgan, R. O. (2007) · Clinical Infectious Diseases · doi:10.1086/516778 · Cited by 566
Metadata
- Authors
- Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., Weinstein, M. C., & Freedberg, K. A.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07
- Volume
- 194
- Issue
- 1
- Pages
- 11-19
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2136683144
- Cited by
- 581
- References
- 42
- FWCI
- 27.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.